SUCROSE

Manufacturer: Uriel Pharmacy Inc.
Effective date: 2018-05-01
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: legacy-cache
Hydrated at: 2026-08-02 00:59:05

Label at a glance#

ProductThuja Thymus comp.

Active ingredientEQUISETUM ARVENSE TOP, LEVISTICUM OFFICINALE ROOT, SLOE, URTICA DIOICA, DRYOPTERIS FILIX-MAS ROOT, FORMICA RUFA, PTERIDIUM AQUILINUM WHOLE, ASPLENIUM SCOLOPENDRIUM TOP, BOS TAURUS THYMUS, MAMMAL LIVER, OSTREA EDULIS SHELL, SILVER, PORK KIDNEY, THUJA OCCIDENTALIS WHOLE, AMANITA MUSCARIA FRUITING BODY, SILICON DIOXIDE, MERCURY

Label structure9 sections

Contacts and useful links#

PhoneLabel contact866.642.2858

Websitewww.urielpharmacy.com

www.urielpharmacy.com

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Directions: FOR ORAL USE ONLY.

DOSAGE & ADMINISTRATION SECTION

Dissolve pellets under the tongue 3-4 times daily. Ages 12 and older: 10 pellets. Ages 2-11: 5 pellets. Under age 2: Consult a doctor.

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Equisetum (Common horsetail) 2X, Levisticum (Lovage) 2X, Prunus spin. (Blackthorn) 2X, Urtica dioica (Stinging nettle) 2X, Filix (Male fern) 3X, Formica (Red wood ant) 3X, Pteridium (Eagle fern) 3X, Scolopendrium (Hart's tongue) 3X, Gland. thymus (Bovine thymus) 4X, Hepar (Bovine liver) 4X, Conchae (Oyster shells) 5X, Argentum met. (Silver) 6X, Renes (Bovine kidneys) 6X, Thuja (American arborvitae) 6X, Agaricus (Fly agaric mushroom) 7X, Quartz (Rock crystal) 12X, Mercurius vivus (Mercury) 14X, Carbo betula (Birch wood charcoal) 20X

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Sucrose, Lactose

OTC - PURPOSE SECTION

Use: Temporary relief of headache.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

WARNINGS SECTION

Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Contains sugar. Diabetics and persons intolerant of sucrose (sugar): Consult a doctor before use. Do not use if allergic to any ingredient. Contains traces of lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.

OTC - QUESTIONS SECTION

Questions? Call 866.642.2858
Uriel, East Troy, WI 53120
www.urielpharmacy.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ThujaThymusCompPellet

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
AMANITA MUSCARIA FRUITING BODY	ACTIVE INGREDIENT	DIF093I037	1
ASPLENIUM SCOLOPENDRIUM TOP	ACTIVE INGREDIENT	HJA3YWQ7HL	1
BOS TAURUS THYMUS	ACTIVE INGREDIENT	8XEJ88V2T8	1
COLLOIDAL SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
DRYOPTERIS FILIX-MAS ROOT	ACTIVE INGREDIENT	C0ZK0RRF5X	1
EQUISETUM ARVENSE TOP	ACTIVE INGREDIENT	1DP6Y6B65Z	1
FORMICA RUFA	ACTIVE INGREDIENT	55H0W83JO5	1
LEVISTICUM OFFICINALE ROOT	ACTIVE INGREDIENT	46QZ19OEX8	1
MAMMAL LIVER	ACTIVE INGREDIENT	D0846624BI	1
MERCURY	ACTIVE INGREDIENT	FXS1BY2PGL	1
OSTREA EDULIS SHELL	ACTIVE INGREDIENT	49OY13BE7Z	1
PORK KIDNEY	ACTIVE INGREDIENT	X7BCI5P86H	1
PTERIDIUM AQUILINUM WHOLE	ACTIVE INGREDIENT	05T3M06HCM	1
SILVER	ACTIVE INGREDIENT	3M4G523W1G	1
SLOE	ACTIVE INGREDIENT	3MLB4858X7	1
THUJA OCCIDENTALIS WHOLE	ACTIVE INGREDIENT	5HBV6WCE3N	1
URTICA DIOICA	ACTIVE INGREDIENT	710FLW4U46	1
AMANITA MUSCARIA FRUITING BODY	ACTIVE MOIETY	DIF093I037	1
ASPLENIUM SCOLOPENDRIUM TOP	ACTIVE MOIETY	HJA3YWQ7HL	1
BOS TAURUS THYMUS	ACTIVE MOIETY	8XEJ88V2T8	1
COLLOIDAL SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	1
DRYOPTERIS FILIX-MAS ROOT	ACTIVE MOIETY	C0ZK0RRF5X	1
EQUISETUM ARVENSE TOP	ACTIVE MOIETY	1DP6Y6B65Z	1
FORMICA RUFA	ACTIVE MOIETY	55H0W83JO5	1
LEVISTICUM OFFICINALE ROOT	ACTIVE MOIETY	46QZ19OEX8	1
MAMMAL LIVER	ACTIVE MOIETY	D0846624BI	1
MERCURY	ACTIVE MOIETY	FXS1BY2PGL	1
OSTREA EDULIS SHELL	ACTIVE MOIETY	49OY13BE7Z	1
PORK KIDNEY	ACTIVE MOIETY	X7BCI5P86H	1
PTERIDIUM AQUILINUM WHOLE	ACTIVE MOIETY	05T3M06HCM	1
SILVER	ACTIVE MOIETY	3M4G523W1G	1
SLOE	ACTIVE MOIETY	3MLB4858X7	1
THUJA OCCIDENTALIS WHOLE	ACTIVE MOIETY	5HBV6WCE3N	1
URTICA DIOICA	ACTIVE MOIETY	710FLW4U46	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

Thuja Thymus comp.
SUCROSE
LACTOSE
EQUISETUM ARVENSE TOP
LEVISTICUM OFFICINALE ROOT
SLOE
URTICA DIOICA
DRYOPTERIS FILIX-MAS ROOT
FORMICA RUFA
PTERIDIUM AQUILINUM WHOLE
ASPLENIUM SCOLOPENDRIUM TOP
BOS TAURUS THYMUS
MAMMAL LIVER
OSTREA EDULIS SHELL
SILVER
PORK KIDNEY
THUJA OCCIDENTALIS WHOLE
AMANITA MUSCARIA FRUITING BODY
SILICON DIOXIDE
MERCURY

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
48951-9005	48951-9005-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
LACTOSE	J2B2A4N98G	IACT
EQUISETUM ARVENSE TOP	1DP6Y6B65Z	ACTIB
LEVISTICUM OFFICINALE ROOT	46QZ19OEX8	ACTIB
SLOE	3MLB4858X7	ACTIB
URTICA DIOICA	710FLW4U46	ACTIB
DRYOPTERIS FILIX-MAS ROOT	C0ZK0RRF5X	ACTIB
FORMICA RUFA	55H0W83JO5	ACTIB
PTERIDIUM AQUILINUM WHOLE	05T3M06HCM	ACTIB
ASPLENIUM SCOLOPENDRIUM TOP	HJA3YWQ7HL	ACTIB
BOS TAURUS THYMUS	8XEJ88V2T8	ACTIB
MAMMAL LIVER	D0846624BI	ACTIB
OSTREA EDULIS SHELL	49OY13BE7Z	ACTIB
SILVER	3M4G523W1G	ACTIB
PORK KIDNEY	X7BCI5P86H	ACTIB
THUJA OCCIDENTALIS WHOLE	5HBV6WCE3N	ACTIB
AMANITA MUSCARIA FRUITING BODY	DIF093I037	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB
MERCURY	FXS1BY2PGL	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 84 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
0f12e34a-9079-d4df-e063-6294a90ab239			1c10ddca-abde-49cd-a30f-d5bfd628f38c	2024-01-16	Warnings	Exact identifier spl set id: 1c10ddca-abde-49cd-a30f-d5bfd628f38c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.